Therapeutic implications of escape from angiotensin-converting enzyme inhibition in patients with chronic heart failure.

Ennezat, P V; Berlowitz, M; Sonnenblick, E H; Le Jemtel, T H

Ennezat, P V; Berlowitz, M; Sonnenblick, E H; Le Jemtel, T H.

Affiliation

Ennezat PV; Albert Einstein College of Medicine, Division of Cardiology, Forchheimer Building, Room G 46,1300 Morris Park Avenue, Bronx, NY 10461, USA.

Curr Cardiol Rep ; 2(3): 258-62, 2000 May.

Article in En | MEDLINE | ID: mdl-10980901

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/administration & dosage; Heart Failure/drug therapy; Animals; Antihypertensive Agents/therapeutic use; Benzimidazoles/therapeutic use; Biphenyl Compounds; Drug Therapy, Combination; Enalapril/administration & dosage; Enalapril/therapeutic use; Heart Failure/physiopathology; Humans; Randomized Controlled Trials as Topic; Tetrazoles/therapeutic use; Ventricular Dysfunction, Left/drug therapy; Ventricular Dysfunction, Left/physiopathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Heart Failure Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Curr Cardiol Rep Journal subject: CARDIOLOGIA Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links